Detalhe da pesquisa
1.
Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.
BMC Pharmacol Toxicol
; 14: 44, 2013 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24004460